-
Netflix to buy Warner Bros. Discovery for nearly $83 billion
-
Sri Lanka issues fresh landslide warnings as toll nears 500
-
Root says England still 'well and truly' in second Ashes Test
-
Chelsea's Maresca says rotation unavoidable
-
Italian president urges Olympic truce at Milan-Cortina torch ceremony
-
Norris edges Verstappen in opening practice for season-ending Abu Dhabi GP
-
Australia race clear of England to seize control of second Ashes Test
-
Trump strategy shifts from global role and vows 'resistance' in Europe
-
Turkey orders arrest of 29 footballers in betting scandal
-
EU hits X with 120-mn-euro fine, risking Trump ire
-
Arsenal's Merino has earned striking role: Arteta
-
Putin offers India 'uninterrupted' oil in summit talks with Modi
-
New Trump strategy vows shift from global role to regional
-
World Athletics ditches long jump take-off zone reform
-
French town offers 1,000-euro birth bonuses to save local clinic
-
After wins abroad, Syria leader must gain trust at home
-
Slot spots 'positive' signs at struggling Liverpool
-
Eyes of football world on 2026 World Cup draw with Trump centre stage
-
South Africa rugby coach Erasmus extends contract until 2031
-
Ex-Manchester Utd star Lingard announces South Korea exit
-
Australia edge ominously within 106 runs of England in second Ashes Test
-
McIlroy survives as Min Woo Lee surges into Australian Open hunt
-
German factory orders rise more than expected
-
Flooding kills two as Vietnam hit by dozens of landslides
-
Italy to open Europe's first marine sanctuary for dolphins
-
Hong Kong university suspends student union after calls for fire justice
-
Asian markets rise ahead of US data, expected Fed rate cut
-
Nigerian nightlife finds a new extravagance: cabaret
-
Tanzania tourism suffers after election killings
-
Yo-de-lay-UNESCO? Swiss hope for yodel heritage listing
-
Weatherald fires up as Australia race to 130-1 in second Ashes Test
-
Georgia's street dogs stir affection, fear, national debate
-
Survivors pick up pieces in flood-hit Indonesia as more rain predicted
-
Gibbs runs for three TDs as Lions down Cowboys to boost NFL playoff bid
-
Pandas and ping-pong: Macron ending China visit on lighter note
-
TikTok to comply with 'upsetting' Australian under-16 ban
-
Hope's resistance keeps West Indies alive in New Zealand Test
-
Pentagon endorses Australia submarine pact
-
India rolls out red carpet for Russia's Putin
-
Softbank's Son says super AI could make humans like fish, win Nobel Prize
-
LeBron scoring streak ends as Hachimura, Reaves lift Lakers
-
England all out for 334 in second Ashes Test
-
Hong Kong university axes student union after calls for fire justice
-
'Annoying' Raphinha pulling Barca towards their best
-
Prolific Kane and Undav face off as Bayern head to Stuttgart
-
Napoli's title defence continues with visit of rivals Juventus
-
Nice host Angers with storm clouds gathering over the Riviera
-
OpenAI strikes deal on US$4.6 bn AI centre in Australia
-
Rains hamper Sri Lanka cleanup after deadly floods
-
In India's mining belt, women spark hope with solar lamps
US regulator approves new generic abortion pill, conservatives outraged
US regulators have approved an additional generic version of the abortion pill mifepristone, a normally routine move that nevertheless angered anti-abortion activists.
A number of conservative figures and anti-abortion groups decried the regulatory step, with the institution Students for Life Action calling it "a stain on the Trump presidency."
The drugmaker Evita said on its website the US Food and Drug Administration had this week approved the company's generic tablet, which is currently approved to end pregnancies up to 70 days of gestation.
The medication is used in the majority of abortions in the United States, and also routinely used for managing early miscarriage.
The FDA originally approved mifepristone in 2000, and another generic already exists.
Approvals of additional generics are typically routine.
But Marjorie Dannenfelser, president of the organization Susan B. Anthony Pro-Life America, called the approval "reckless" and "unconscionable" in a statement Thursday.
Senator Josh Hawley, a Republican from Missouri, said on X he had "lost confidence" in FDA leadership while former vice president Mike Pence posted it was "a complete betrayal of the pro-life movement that elected President Trump."
Pence also called for the dismissal of Robert F. Kennedy Jr, Trump's controversial health chief.
The ruckus comes weeks after Kennedy and FDA Commissioner Marty Makary reportedly delivered a letter to 22 Republican attorneys general saying the FDA was conducting a new review of mifepristone's safety.
Abortion rights organizations have dubbed that a blatant attempt to undermine health care access, and a coalition of attorneys general from more than a dozen Democratic-led states vowed to protect availability of the drug.
The American Medical Association has called the prescription drug "exceedingly safe and effective" and said restricting access to mifepristone would "jeopardize public health."
That take echoes the positions of many leading medical institutions.
Mifepristone, which prevents pregnancy progression, is generally used in combination with misoprostol, which empties the uterus.
V.Fontes--PC